Jordan Feld from Toronto Western Hospital Liver Centre and colleagues evaluated the safety and efficacy of different combination regimens containing the second-generation HCV protease inhibitor danoprevir, the nucleoside HCV polymerase inhibitor mericitabine, ribavirin, and for some participants, pegylated interferon alfa-2a (Pegasys).
Danoprevir is boosted with a small amount of ritonavir (Norvir) to reach higher levels in the body.
Danoprevir is boosted with a small amount of ritonavir (Norvir) to reach higher levels in the body.
All AASLD Coverage @ HIV and Hepatitis
Highlights
Liver Meeting Highlights: New Hep C Drugs, NAFLD, Liver Cancer, Acetaminophen Toxicity, Benefits of Coffee
No comments:
Post a Comment